(Q40093350)

17 September 2017

title

Neurotransmitter receptor alterations in Parkinson's disease (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

29 December 2022

1 reference

1 reference

T. D. Reisine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197361

29 December 2022

J. Z. Fields

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197361

29 December 2022

H. I. Yamamura

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197361

29 December 2022

language of work or name

English

0 references

publication date

1 August 1977

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0024320577905148?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

https://api.elsevier.com/content/article/PII:0024320577905148?httpAccept=text/plain

29 December 2022

1 reference

Crossref

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

29 December 2022

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

335-343

1 reference

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Six years of high-level levodopa therapy in severely akinetic parkinsonian patients

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Neurotransmitter Receptors in the Brain: Biochemical Identification

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Protein measurement with the Folin phenol reagent

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Alterations of brain neurotransmitter receptor binding in Huntington's chorea

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Neurotransmitter receptor binding: regional distribution in human brain

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Huntington's chorea. Changes in neurotransmitter receptors in the brain

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Alterations in dopaminergic receptors in Huntington's disease

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Influence of noncholinergic drugs on rat striatal acetylcholine levels

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Success and problems of long-term levodopa therapy in Parkinson's disease

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Treatment of parkinson's disease with bromocriptine

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90514-8

29 December 2022

Identifiers

1 reference

17 September 2017

1 reference